Elimination of Australian epidemic strain (AES1) pseudomonas aeruginosa in a pediatric cystic fibrosis center.
Ajay C KevatRosemary CarzinoJohn MassieJo HarrisonAmanda L GriffithsPublished in: Pediatric pulmonology (2018)
Cohort segregation was associated with reduction in AES1 prevalence ascertained by PFGE surveillance for patients in a single large pediatric cystic fibrosis center. Other alterations in practice such as early eradication treatment may also have contributed to reduced PsA prevalence. These factors combined with the transition of chronically infected patients over time to adult centers has eliminated AES1 from our clinic, with an accompanying mortality decrease.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- risk factors
- end stage renal disease
- primary care
- prostate cancer
- lung function
- ejection fraction
- chronic kidney disease
- newly diagnosed
- public health
- biofilm formation
- healthcare
- peritoneal dialysis
- prognostic factors
- acinetobacter baumannii
- cardiovascular events
- helicobacter pylori infection
- air pollution
- chronic obstructive pulmonary disease
- helicobacter pylori
- escherichia coli
- radical prostatectomy
- young adults